Loading company…
Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.
Respana Therapeutics, Inc has been awarded 3 US Small Business Innovation Research (SBIR/STTR) contracts totalling $3,062,095 between 2018 and 2023. These are non-dilutive federal research grants, not equity financing. The company is based in Philadelphia, Pennsylvania.
No investors recorded yet for Respana Therapeutics, Inc.
Add an investorRespana Therapeutics, Inc has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Respana Therapeutics, Inc.
Add diversity data